The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. PHOENIX, Oct. 17, 2023 -- SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts and...
SenesTech to Participate in the Lytham Partners Fall 2023 Investor Conference
PHOENIX, Oct. 9, 2023 -- SenesTech, Inc. (NASDAQ: SNES) today announced that Joel Fruendt, Chief Executive Officer, and Tom Chesterman, Chief Financial Officer, will present and host one-on-one meetings with investors at the Lytham Partners Fall 2023 Investor...
ContraPest® Deploying at Waste Water Treatment Facilities
PHOENIX, Sept. 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that...
SenesTech Announces Closing of Warrant Exercise for $2.1 Million in Gross Proceeds
Isolate Bait System™ Now Shipping PHOENIX, Aug. 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
SenesTech Announces Second Quarter 2023 Financial Results
July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and...
SenesTech to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 3, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on...
SenesTech Launches Isolate Bait System™ for Contrapest®
Single step deployment system increases market potential while reducing install times by 80% Incorporates Enhanced ContraPest Formulation for Improved Performance in the Field PHOENIX, July 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),...
SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023
PHOENIX, May 15, 2023 -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a...
SenesTech Announces First Quarter 2023 Financial Results
E-Commerce Leads Growth at 54% Year Over Year PHOENIX, May 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female...
SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on...